Turkey and Russia will grow 12%-13% next year, to $85 billion-$95 billion, as primary care improves and expands into rural areas and private insurance becomes more widely held, shifting the focus of treatment away from infectious diseases and towards cardiovascular disease, diabetes and other chronic illnesses.